In Reply to Xue W, Ribalov R, Zhou Z-Y et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113

Michael Serbin,Charles Yonan,Michael L. Ganz

In Reply to Xue W, Ribalov R, Zhou Z-Y et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113

2021

Michael Serbin
Charles Yonan
Michael L. Ganz

Dear Editor,We appreciate the interest from Xue et al. in our cost-effectiveness analysis of valbenazine versus deutetrabenazine for the treatment of tardive dyskinesia (TD)1, and are gratified tha...

Keywords:

Gynecology
Tardive dyskinesia
Medicine
cost effectiveness
Valbenazine
Deutetrabenazine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations